Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,920 | -9,040 | 180 | 12,490 | 5,540 |
| Depreciation Amortization | 3,530 | 2,270 | 870 | 2,530 | 1,660 |
| Other Working Capital | 10,190 | 5,150 | -3,970 | -20,140 | -8,860 |
| Other Operating Activity | -2,980 | -2,650 | -2,350 | 970 | 1,680 |
| Operating Cash Flow | $-10,180 | $-4,270 | $-5,270 | $-4,150 | $20 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,590 | -5,640 | -870 | -13,290 | -12,400 |
| Other Investing Activity | 2,810 | -10,170 | -9,380 | 15,360 | 0 |
| Investing Cash Flow | $-4,780 | $-15,810 | $-10,250 | $2,070 | $-12,400 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 12,490 | 16,690 | 12,590 | 5,080 | 1,030 |
| Financing Cash Flow | $12,490 | $16,690 | $12,590 | $5,080 | $1,030 |
| Exchange Rate Effect | -510 | -280 | -330 | 370 | -2,570 |
| Beginning Cash Position | 4,590 | 4,590 | 4,590 | 1,190 | 109,610 |
| End Cash Position | 1,600 | 910 | 1,330 | 4,590 | 95,690 |
| Net Cash Flow | $-2,980 | $-3,670 | $-3,250 | $3,390 | $-13,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,180 | -4,270 | -5,270 | -4,150 | 20 |
| Free Cash Flow | -10,180 | -4,270 | -5,270 | -4,150 | 20 |